EU approves Roche's Cotellic in combo therapy against skin cancer
November 25, 2015 at 09:51 AM EST
ZURICH, Nov 25 (Reuters) - The European Union gave its green light to Roche's Cotellic for use in combination with the drug Zelboraf against advanced melanoma, the company said on Wednesday.
